nodes	percent_of_prediction	percent_of_DWPC	metapath
Naproxen—PTGS2—Nicotinate metabolism—NMNAT1—age related macular degeneration	0.105	0.105	CbGpPWpGaD
Naproxen—AKR1C3—Diseases associated with visual transduction—RDH8—age related macular degeneration	0.0543	0.0543	CbGpPWpGaD
Naproxen—AKR1C3—Diseases associated with visual transduction—RPE65—age related macular degeneration	0.0475	0.0475	CbGpPWpGaD
Naproxen—AKR1C3—Diseases associated with visual transduction—ABCA4—age related macular degeneration	0.0383	0.0383	CbGpPWpGaD
Naproxen—AKR1C3—Diseases associated with visual transduction—RHO—age related macular degeneration	0.0333	0.0333	CbGpPWpGaD
Naproxen—ALB—HDL-mediated lipid transport—CETP—age related macular degeneration	0.0231	0.0231	CbGpPWpGaD
Naproxen—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC16A8—age related macular degeneration	0.0203	0.0203	CbGpPWpGaD
Naproxen—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—NMNAT1—age related macular degeneration	0.0201	0.0201	CbGpPWpGaD
Naproxen—AKR1C3—Retinoid metabolism and transport—APOE—age related macular degeneration	0.0196	0.0196	CbGpPWpGaD
Naproxen—CYP1A2—Melatonin metabolism and effects—MAP2—age related macular degeneration	0.0172	0.0172	CbGpPWpGaD
Naproxen—PTGS1—Overview of nanoparticle effects—CRP—age related macular degeneration	0.0162	0.0162	CbGpPWpGaD
Naproxen—ALB—Platelet degranulation—SERPING1—age related macular degeneration	0.0152	0.0152	CbGpPWpGaD
Naproxen—ALB—Response to elevated platelet cytosolic Ca2+—SERPING1—age related macular degeneration	0.0145	0.0145	CbGpPWpGaD
Naproxen—ALB—Lipoprotein metabolism—LIPC—age related macular degeneration	0.0138	0.0138	CbGpPWpGaD
Naproxen—ALB—Lipoprotein metabolism—CETP—age related macular degeneration	0.0133	0.0133	CbGpPWpGaD
Naproxen—PTGS2—Overview of nanoparticle effects—CRP—age related macular degeneration	0.0128	0.0128	CbGpPWpGaD
Naproxen—PTGS2—S1P1 pathway—KDR—age related macular degeneration	0.0123	0.0123	CbGpPWpGaD
Naproxen—ALB—HDL-mediated lipid transport—APOE—age related macular degeneration	0.0123	0.0123	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.0113	0.0113	CbGpPWpGaD
Naproxen—AKR1C3—Diseases associated with visual transduction—APOE—age related macular degeneration	0.01	0.01	CbGpPWpGaD
Naproxen—SLCO1A2—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.00979	0.00979	CbGpPWpGaD
Naproxen—SLC22A6—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.0092	0.0092	CbGpPWpGaD
Naproxen—ALB—Lipid and lipoprotein metabolism—LIPC—age related macular degeneration	0.00916	0.00916	CbGpPWpGaD
Naproxen—ALB—Lipid and lipoprotein metabolism—CETP—age related macular degeneration	0.00884	0.00884	CbGpPWpGaD
Naproxen—UGT2B7—NRF2 pathway—SQSTM1—age related macular degeneration	0.0079	0.0079	CbGpPWpGaD
Naproxen—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—age related macular degeneration	0.00778	0.00778	CbGpPWpGaD
Naproxen—ALB—Lipoprotein metabolism—APOE—age related macular degeneration	0.00705	0.00705	CbGpPWpGaD
Naproxen—PTGS2—Aryl Hydrocarbon Receptor—CD36—age related macular degeneration	0.00702	0.00702	CbGpPWpGaD
Naproxen—AKR1C3—Disease—NMNAT1—age related macular degeneration	0.0069	0.0069	CbGpPWpGaD
Naproxen—AKR1C3—Disease—RDH8—age related macular degeneration	0.0069	0.0069	CbGpPWpGaD
Naproxen—PTGS2—S1P1 pathway—VEGFA—age related macular degeneration	0.00678	0.00678	CbGpPWpGaD
Naproxen—ALB—Platelet activation, signaling and aggregation—SERPING1—age related macular degeneration	0.00676	0.00676	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00649	0.00649	CbGpPWpGaD
Naproxen—UGT1A1—NRF2 pathway—SQSTM1—age related macular degeneration	0.00642	0.00642	CbGpPWpGaD
Naproxen—ALB—Binding and Uptake of Ligands by Scavenger Receptors—CD36—age related macular degeneration	0.00622	0.00622	CbGpPWpGaD
Naproxen—AKR1C3—Disease—RPE65—age related macular degeneration	0.00603	0.00603	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—NMNAT1—age related macular degeneration	0.00578	0.00578	CbGpPWpGaD
Naproxen—SLCO1A2—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00558	0.00558	CbGpPWpGaD
Naproxen—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—age related macular degeneration	0.00549	0.00549	CbGpPWpGaD
Naproxen—SLC22A6—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00525	0.00525	CbGpPWpGaD
Naproxen—CYP1A2—Melatonin metabolism and effects—APOE—age related macular degeneration	0.00507	0.00507	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—ELOVL4—age related macular degeneration	0.00505	0.00505	CbGpPWpGaD
Naproxen—SLCO1A2—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00498	0.00498	CbGpPWpGaD
Naproxen—SLCO1A2—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00498	0.00498	CbGpPWpGaD
Naproxen—PTGS1—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00494	0.00494	CbGpPWpGaD
Naproxen—AKR1C3—Disease—ABCA4—age related macular degeneration	0.00486	0.00486	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—RDH8—age related macular degeneration	0.00483	0.00483	CbGpPWpGaD
Naproxen—ALB—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.00478	0.00478	CbGpPWpGaD
Naproxen—PTGS1—Selenium Micronutrient Network—CRP—age related macular degeneration	0.00474	0.00474	CbGpPWpGaD
Naproxen—ALB—Vitamin B12 Metabolism—CRP—age related macular degeneration	0.00471	0.00471	CbGpPWpGaD
Naproxen—ALB—Lipid and lipoprotein metabolism—APOE—age related macular degeneration	0.00468	0.00468	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.00468	0.00468	CbGpPWpGaD
Naproxen—SLC22A6—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00468	0.00468	CbGpPWpGaD
Naproxen—SLC22A6—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00468	0.00468	CbGpPWpGaD
Naproxen—ALB—Vitamin B12 Metabolism—APOE—age related macular degeneration	0.00461	0.00461	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.00452	0.00452	CbGpPWpGaD
Naproxen—AKR1C3—Disease—RHO—age related macular degeneration	0.00423	0.00423	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—RPE65—age related macular degeneration	0.00422	0.00422	CbGpPWpGaD
Naproxen—PTGS2—Integrated Pancreatic Cancer Pathway—CST3—age related macular degeneration	0.00412	0.00412	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—SLC16A8—age related macular degeneration	0.00407	0.00407	CbGpPWpGaD
Naproxen—CYP1A2—Aryl Hydrocarbon Receptor—CD36—age related macular degeneration	0.00397	0.00397	CbGpPWpGaD
Naproxen—PTGS2—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00392	0.00392	CbGpPWpGaD
Naproxen—PTGS1—Selenium Micronutrient Network—CCL2—age related macular degeneration	0.0039	0.0039	CbGpPWpGaD
Naproxen—ALB—Vitamin B12 Metabolism—CCL2—age related macular degeneration	0.00388	0.00388	CbGpPWpGaD
Naproxen—ALB—Folate Metabolism—CRP—age related macular degeneration	0.00383	0.00383	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—NMNAT1—age related macular degeneration	0.0038	0.0038	CbGpPWpGaD
Naproxen—PTGS2—Selenium Micronutrient Network—CRP—age related macular degeneration	0.00376	0.00376	CbGpPWpGaD
Naproxen—ALB—Hemostasis—F13B—age related macular degeneration	0.00371	0.00371	CbGpPWpGaD
Naproxen—PTGS2—Integrated Pancreatic Cancer Pathway—TGFBR1—age related macular degeneration	0.0037	0.0037	CbGpPWpGaD
Naproxen—ALB—Platelet degranulation—CD36—age related macular degeneration	0.00365	0.00365	CbGpPWpGaD
Naproxen—ALB—Hemostasis—SERPING1—age related macular degeneration	0.00348	0.00348	CbGpPWpGaD
Naproxen—ALB—Response to elevated platelet cytosolic Ca2+—CD36—age related macular degeneration	0.00347	0.00347	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—ABCA4—age related macular degeneration	0.00341	0.00341	CbGpPWpGaD
Naproxen—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—age related macular degeneration	0.00334	0.00334	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—ELOVL4—age related macular degeneration	0.00332	0.00332	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—NMNAT1—age related macular degeneration	0.00331	0.00331	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00319	0.00319	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00317	0.00317	CbGpPWpGaD
Naproxen—ALB—Folate Metabolism—CCL2—age related macular degeneration	0.00315	0.00315	CbGpPWpGaD
Naproxen—PTGS2—Selenium Micronutrient Network—CCL2—age related macular degeneration	0.0031	0.0031	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—NMNAT1—age related macular degeneration	0.00309	0.00309	CbGpPWpGaD
Naproxen—ALB—Selenium Micronutrient Network—CRP—age related macular degeneration	0.00305	0.00305	CbGpPWpGaD
Naproxen—ALB—Hemostasis—RAD51B—age related macular degeneration	0.00302	0.00302	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—RHO—age related macular degeneration	0.00296	0.00296	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—ELOVL4—age related macular degeneration	0.00289	0.00289	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—TLR4—age related macular degeneration	0.00285	0.00285	CbGpPWpGaD
Naproxen—ALB—Hemostasis—SLC16A8—age related macular degeneration	0.00281	0.00281	CbGpPWpGaD
Naproxen—ALB—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00273	0.00273	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.00271	0.00271	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—ELOVL4—age related macular degeneration	0.0027	0.0027	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.00268	0.00268	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—SLC16A8—age related macular degeneration	0.00268	0.00268	CbGpPWpGaD
Naproxen—AKR1C3—Disease—CST3—age related macular degeneration	0.00265	0.00265	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.0026	0.0026	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.00258	0.00258	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—NMNAT1—age related macular degeneration	0.00252	0.00252	CbGpPWpGaD
Naproxen—ALB—Selenium Micronutrient Network—CCL2—age related macular degeneration	0.0025	0.0025	CbGpPWpGaD
Naproxen—SLCO1A2—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00246	0.00246	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—CCL2—age related macular degeneration	0.00245	0.00245	CbGpPWpGaD
Naproxen—ALB—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00243	0.00243	CbGpPWpGaD
Naproxen—ALB—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00243	0.00243	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.00239	0.00239	CbGpPWpGaD
Naproxen—PTGS2—Disease—NMNAT1—age related macular degeneration	0.00239	0.00239	CbGpPWpGaD
Naproxen—PTGS2—Disease—RDH8—age related macular degeneration	0.00239	0.00239	CbGpPWpGaD
Naproxen—AKR1C3—Disease—TGFBR1—age related macular degeneration	0.00237	0.00237	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—SLC16A8—age related macular degeneration	0.00233	0.00233	CbGpPWpGaD
Naproxen—SLC22A6—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00231	0.00231	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00222	0.00222	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—ELOVL4—age related macular degeneration	0.0022	0.0022	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—SLC16A8—age related macular degeneration	0.00217	0.00217	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—LIPC—age related macular degeneration	0.00208	0.00208	CbGpPWpGaD
Naproxen—PTGS2—Disease—RPE65—age related macular degeneration	0.00208	0.00208	CbGpPWpGaD
Naproxen—PTGS1—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.00204	0.00204	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—CETP—age related macular degeneration	0.00201	0.00201	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—NMNAT1—age related macular degeneration	0.002	0.002	CbGpPWpGaD
Naproxen—PTGS1—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.00197	0.00197	CbGpPWpGaD
Naproxen—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—age related macular degeneration	0.00189	0.00189	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—SLC16A8—age related macular degeneration	0.00177	0.00177	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—ELOVL4—age related macular degeneration	0.00175	0.00175	CbGpPWpGaD
Naproxen—ALB—Platelet degranulation—VEGFA—age related macular degeneration	0.00174	0.00174	CbGpPWpGaD
Naproxen—PTGS2—Disease—ABCA4—age related macular degeneration	0.00168	0.00168	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—TGFBR1—age related macular degeneration	0.00166	0.00166	CbGpPWpGaD
Naproxen—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—age related macular degeneration	0.00165	0.00165	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—NMNAT1—age related macular degeneration	0.00163	0.00163	CbGpPWpGaD
Naproxen—PTGS2—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.00162	0.00162	CbGpPWpGaD
Naproxen—ALB—Platelet activation, signaling and aggregation—CD36—age related macular degeneration	0.00162	0.00162	CbGpPWpGaD
Naproxen—ALB—Metabolism—NMNAT1—age related macular degeneration	0.00162	0.00162	CbGpPWpGaD
Naproxen—PTGS2—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.00156	0.00156	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.00155	0.00155	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—SQSTM1—age related macular degeneration	0.00151	0.00151	CbGpPWpGaD
Naproxen—PTGS2—Disease—RHO—age related macular degeneration	0.00146	0.00146	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—ELOVL4—age related macular degeneration	0.00142	0.00142	CbGpPWpGaD
Naproxen—ALB—Metabolism—ELOVL4—age related macular degeneration	0.00141	0.00141	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—SLC16A8—age related macular degeneration	0.00141	0.00141	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.00137	0.00137	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—LIPC—age related macular degeneration	0.00137	0.00137	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—NMNAT1—age related macular degeneration	0.00132	0.00132	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—CETP—age related macular degeneration	0.00132	0.00132	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.00132	0.00132	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.00131	0.00131	CbGpPWpGaD
Naproxen—AKR1C3—Disease—APOE—age related macular degeneration	0.00127	0.00127	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.00127	0.00127	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.00126	0.00126	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—CD36—age related macular degeneration	0.00121	0.00121	CbGpPWpGaD
Naproxen—ALB—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.0012	0.0012	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—LIPC—age related macular degeneration	0.00119	0.00119	CbGpPWpGaD
Naproxen—PTGS1—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.00118	0.00118	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—ELOVL4—age related macular degeneration	0.00116	0.00116	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—CETP—age related macular degeneration	0.00115	0.00115	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—SLC16A8—age related macular degeneration	0.00115	0.00115	CbGpPWpGaD
Naproxen—ALB—Metabolism—SLC16A8—age related macular degeneration	0.00114	0.00114	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—NMNAT1—age related macular degeneration	0.00113	0.00113	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—LIPC—age related macular degeneration	0.00111	0.00111	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—CETP—age related macular degeneration	0.00107	0.00107	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.00107	0.00107	CbGpPWpGaD
Naproxen—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	0.00107	0.00107	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—APOE—age related macular degeneration	0.00107	0.00107	CbGpPWpGaD
Naproxen—PTGS1—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.00104	0.00104	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.00103	0.00103	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—ELOVL4—age related macular degeneration	0.000988	0.000988	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—C3—age related macular degeneration	0.000958	0.000958	CbGpPWpGaD
Naproxen—PTGS2—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000938	0.000938	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—SLC16A8—age related macular degeneration	0.000932	0.000932	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000915	0.000915	CbGpPWpGaD
Naproxen—PTGS2—Disease—CST3—age related macular degeneration	0.000914	0.000914	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—LIPC—age related macular degeneration	0.000908	0.000908	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—APOE—age related macular degeneration	0.000892	0.000892	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000883	0.000883	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—CETP—age related macular degeneration	0.000876	0.000876	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—KDR—age related macular degeneration	0.000874	0.000874	CbGpPWpGaD
Naproxen—ALB—Hemostasis—CD36—age related macular degeneration	0.000834	0.000834	CbGpPWpGaD
Naproxen—PTGS2—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000827	0.000827	CbGpPWpGaD
Naproxen—PTGS2—Disease—TGFBR1—age related macular degeneration	0.000821	0.000821	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—SLC16A8—age related macular degeneration	0.000796	0.000796	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—CD36—age related macular degeneration	0.000794	0.000794	CbGpPWpGaD
Naproxen—ALB—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	0.00077	0.00077	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000763	0.000763	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000759	0.000759	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—CCL2—age related macular degeneration	0.00075	0.00075	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—LIPC—age related macular degeneration	0.00072	0.00072	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—APOE—age related macular degeneration	0.000701	0.000701	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—CETP—age related macular degeneration	0.000695	0.000695	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—CD36—age related macular degeneration	0.000692	0.000692	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000673	0.000673	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000669	0.000669	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—CD36—age related macular degeneration	0.000645	0.000645	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000621	0.000621	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—APOE—age related macular degeneration	0.00061	0.00061	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—LIPC—age related macular degeneration	0.000586	0.000586	CbGpPWpGaD
Naproxen—ALB—Metabolism—LIPC—age related macular degeneration	0.000583	0.000583	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—APOE—age related macular degeneration	0.000569	0.000569	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—CETP—age related macular degeneration	0.000566	0.000566	CbGpPWpGaD
Naproxen—ALB—Metabolism—CETP—age related macular degeneration	0.000562	0.000562	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000548	0.000548	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000531	0.000531	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—CD36—age related macular degeneration	0.000526	0.000526	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—VEGFA—age related macular degeneration	0.000481	0.000481	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—LIPC—age related macular degeneration	0.000477	0.000477	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000468	0.000468	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—APOE—age related macular degeneration	0.000464	0.000464	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—CETP—age related macular degeneration	0.00046	0.00046	CbGpPWpGaD
Naproxen—PTGS2—Disease—APOE—age related macular degeneration	0.00044	0.00044	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—CD36—age related macular degeneration	0.000418	0.000418	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—LIPC—age related macular degeneration	0.000408	0.000408	CbGpPWpGaD
Naproxen—ALB—Hemostasis—VEGFA—age related macular degeneration	0.000397	0.000397	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—CETP—age related macular degeneration	0.000393	0.000393	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—APOE—age related macular degeneration	0.000369	0.000369	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—CD36—age related macular degeneration	0.00034	0.00034	CbGpPWpGaD
Naproxen—ALB—Metabolism—CD36—age related macular degeneration	0.000338	0.000338	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—APOE—age related macular degeneration	0.0003	0.0003	CbGpPWpGaD
Naproxen—ALB—Metabolism—APOE—age related macular degeneration	0.000298	0.000298	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—CD36—age related macular degeneration	0.000277	0.000277	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—APOE—age related macular degeneration	0.000244	0.000244	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—CD36—age related macular degeneration	0.000236	0.000236	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—APOE—age related macular degeneration	0.000209	0.000209	CbGpPWpGaD
